Literature DB >> 11369157

Physiological changes and clinical correlations of dyspnea in cancer outpatients.

D J Dudgeon1, M Lertzman, G R Askew.   

Abstract

The purposes of this cross-sectional study of 75 outpatients of a general oncology clinic were to assess the subjective and objective factors associated with dyspnea in cancer patients and to characterize factors that might contribute to respiratory muscle weakness demonstrated in a previous study. Patients with moderate to severe shortness of breath completed visual analogue scales (VAS) of shortness of breath (SOB) and anxiety; other data were acquired from pulmonary function tests, including maximum inspiratory pressure (MIP) and expiratory pressures; chest radiography; arterial blood gases; measurement of hemoglobin, serum potassium, phosphate, calcium, albumin, and magnesium; and ultrasound study of the diaphragm for thickness and excursion. The correlation coefficient between SOB VAS and anxiety VAS was 0.26 (P = 0.03). In stepwise multiple regression analyses, only the regression coefficient for anxiety remained significant at P < 0.05 in the multivariate model with SOB VAS as the dependent variable. The multivariate model using MIP (a measure of respiratory muscle strength) as the dependent variable, found significance for total diaphragmatic excursion, hemoglobin, phosphate, residual volume over total lung volume, vital capacity, percent predicted total lung capacity, oxygen saturation, and forced vital capacity. The regression coefficients for these variables were significant at P < 0.05 and the model accounted for 58% of the variance of MIP.

Entities:  

Mesh:

Year:  2001        PMID: 11369157     DOI: 10.1016/s0885-3924(01)00278-0

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  15 in total

Review 1.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

2.  Evaluation of diagnostic and treatment approaches towards acute dyspnea in a palliative care setting among medical students at the University of Vienna.

Authors:  Gudrun Pohl; Christine Marosi; Karin Dieckmann; Gregor Goldner; Katarzyna Elandt; Marco Hassler; Michael Schemper; Kathrin Strasser-Weippl; Friedemann Nauck; Jan Gaertner; Herbert Watzke
Journal:  Wien Med Wochenschr       Date:  2012-01

Review 3.  Management of Physical Symptoms in Patients with Advanced Cancer during the Last Weeks and Days of Life.

Authors:  Ahsan Azhar; David Hui
Journal:  Cancer Res Treat       Date:  2022-06-30       Impact factor: 5.036

4.  Additional evidence for the affective dimension of dyspnea in patients with COPD.

Authors:  Virginia Carrieri-Kohlman; DorAnne Donesky-Cuenco; Soo Kyung Park; Lynda Mackin; Huong Q Nguyen; Steven M Paul
Journal:  Res Nurs Health       Date:  2010-02       Impact factor: 2.228

5.  Oral morphine and respiratory function amongst hospice inpatients with advanced cancer.

Authors:  T D Walsh; N I Rivera; R Kaiko
Journal:  Support Care Cancer       Date:  2003-10-24       Impact factor: 3.603

6.  Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates.

Authors:  David Hui; Margarita Morgado; Marieberta Vidal; Laura Withers; Quan Nguyen; Gary Chisholm; Clarence Finch; Eduardo Bruera
Journal:  J Palliat Med       Date:  2013-02-11       Impact factor: 2.947

7.  Newly diagnosed patients with advanced non-small cell lung cancer: A clinical description of those with moderate to severe depressive symptoms.

Authors:  B L Andersen; T R Valentine; S B Lo; D P Carbone; C J Presley; P G Shields
Journal:  Lung Cancer       Date:  2019-11-21       Impact factor: 5.705

Review 8.  Oxygen or air for palliation of breathlessness in advanced cancer.

Authors:  Sara Booth; Rosemary Wade
Journal:  J R Soc Med       Date:  2003-05       Impact factor: 18.000

9.  Anemia and hemoglobin serum levels are associated with exercise capacity and quality of life in chronic obstructive pulmonary disease.

Authors:  Marcello Ferrari; Lorenzo Manea; Kamel Anton; Paola Bruzzone; Mara Meneghello; Francesco Zamboni; Luigi Purgato; Lucia Cazzoletti; Pietro Ferrari; Renato Testi
Journal:  BMC Pulm Med       Date:  2015-05-08       Impact factor: 3.317

10.  A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion.

Authors:  S H Ahmedzai; E Laude; A Robertson; G Troy; V Vora
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.